Table 1 Study design, demographic data, study characteristics and MINORS scores for studies included in the meta-analysis
References | Study design | No. of patients | Age (range) (years) | Male sex (%) | Reason for ORIF | F/U period (years) | Delbet classification | Surgery delay (range) | Implant used | MINORS score | |
|---|---|---|---|---|---|---|---|---|---|---|---|
ORIF | CRIF | ||||||||||
Azam et al. [18] | RCS | 8 | 14 | 9.0 (5−15) | 63.6 | N/A |  > 2 | II: 59%, III: 41% | 11.2 days (2−21) | N/A | 19 |
Bali et al. [19] | RCS | 18 | 13 | 10.0 (3−16) | 55.6 | Patient profile, fracture pattern | 3.2 | II: 48.4%, III: 25.8%, IV: 25.8% | N/A | CCS, FAD | 19 |
Cheng et al. [20] | RCS | 3 | 7 | 12.9 (9−16) | 70.0 | Failure of CR | 4.6 | I: 7%, II: 57%, III: 29%, IV: 7% |  < 24 h | CCS, FAD | 18 |
Dai et al. [30] | RCS | 31 | 13 | 9.0 (2−14) | 61.0 | Patient profile, fracture pattern | 4.8 | I: 2%, II: 57%, III: 41% | 4.3 days (1−19) | CCS, FAD | 19 |
Dendane et al. [21] | RCS | 13 | 8 | 12.1 (5−16) | 66.7 | Failure of CR | 2.2 | II: 42.9%, III: 47.6%, IV: 9.5% | 4.9 days (0.5−21) | Pin, CCS, FAD | 17 |
Dhammi et al. [22] | RCS | 9 | 17 | 10.8 (3−17) | 53.8 | Failure of CR | 2 | II: 38.5%, III: 61.5% | N/A | Pin, CCS | 17 |
Inan et al. [23] | RCS | 5 | 34 | 11.1 (4−16) | 56.4 | Failure of CR | 3.4 | II: 53.8%, III: 35.9%, IV: 10.3% |  ≤ 24 h: 26, > 24 h: 13 | K-wire, CCS, FAD | 18 |
Ju et al. [24] | RCS | 37 | 21 | 9.1 (1.7−15.6) | 69.0 | Failure of CR | 2.9 | II: 51.7%, III: 36.2%, IV: 12.1% | 4.7 days (4.29 CR, 4.89 OR) | K-wire, CCS, FAD | 17 |
Lin et al. [25] | RCS | 19 | 15 | 8.0 | 58.8 | N/A | 1 − 3 | II: 73.5%, III: 26.5% | N/A | K-wire, CCS | 17 |
Moon et al. [31] | RCS | 6 | 16 | 8 (1.5−16) | 50.0 | N/A | 4.0 | II: 32%, III: 40%, IV: 28% | 1.5 days | Pin, CCS | 19 |
Song et al. [26] | RCS | 15 | 12 | 9.9 (5−16) | 40.7 | Period | 2.8 | II: 55.6%, III: 44.4% |  ≤ 24 h: 24, > 24 h: 3 | Pin, K-wire, CCS, FAD | 19 |
Stone et al. [27] | RCS | 6 | 16 | 11.5 (4.5−17.4) | 59.1 | N/A | 2.1 | II: 59.1%, III: 36.4%, IV: 4.5% |  ≤ 24 h: 18, > 24 h: 4 | K-wire, CCS, FAD | 20 |
Varshney et al. [28] | RCS | 8 | 13 | 11.8 (5−15) | 66.6 | Failure of CR | 6.8 | II: 66.6%, III: 33.3% | 8.1 days (2−22) | CCS | 17 |
Wang et al. [29] | RCS | 138 | 103 | 10.0 (2−17) | 56.9 | N/A | 1.6 | I: 2.1%, II: 67.6%, III: 29.9%, IV: 0.4% | 3.7 days | K-wire, CCS, FAD | 17 |
Wu et al. [3] | RCS | 8 | 9 | 10.4 (1−14) | 58.8 | Patient profile, fracture pattern | 1.9 | I: 12.5%, II: 68.8%, III: 18.8% | 3.5 days (1.1−10.0) | K-wire, CCS | 19 |